Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue

被引：103
|
作者：
Russell-Jones, David [1 ]
机构：
[1] Royal Surrey Cty Hosp, Dept Endocrinol & Diabet, Guildford GU2 7XX, Surrey, England
来源：
MOLECULAR AND CELLULAR ENDOCRINOLOGY | 2009年 / 297卷 / 1-2期
关键词：
GLP-1; analogue; Hypoglycaemia; Body weight; Systolic blood pressure; GLUCAGON-LIKE PEPTIDE-1; GLYCEMIC CONTROL; GENE-EXPRESSION; BETA-CELLS; DERIVATIVES; WEIGHT; SULFONYLUREA; NN2211;
D O I：
10.1016/j.mce.2008.11.018
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Liraglutide, a human glucagon-like peptide 1 (GLP-1) analogue with high homology to native GLP-1, has structural modifications sufficient to amend pharmacokinetics for once-daily administration without compromising biological activity. Data from large, controlled, clinical Studies have confirmed the therapeutic profile of liraglutide, with robust reductions in HbA(1c), low risk of hypoglycaemia and clinically relevant reductions in body weight and systolic blood pressure. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：137 / 140
页数：4
相关论文
共 50 条
  • [1] The effect of the once-daily human GLP-1 analogue liraglutide on the pharmacokinetics of paracetamol
    Kapitza, Christoph
    Flint, Anne
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A593 - A593
  • [2] New Aspects to the Once-Daily GLP-1 Mimetic Liraglutide
    Schneider, S.
    DIABETES STOFFWECHSEL UND HERZ, 2009, 18 (05): : 395 - 402
  • [3] The once-daily human GLP-1 analogue liraglutide decreases postprandial hunger and energy intake
    Flint, Anne
    Kapitza, Christoph
    Hinds-Berger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A165 - A165
  • [4] The molecular basis for the delayed absorption of the once-daily human GLP-1 analoge, liraglutide
    Steensgaard, Dorte B.
    Thomsen, Jens K.
    Olsen, Helle B.
    Knudsen, Lotte B.
    DIABETES, 2008, 57 : A164 - A164
  • [5] Mechanism of Protraction for Liraglutide, the Once-Daily Human GLP-1 Analog
    Knudsen, Lotte B.
    Nielsen, Per F.
    Steensgaard, Dorte B.
    Bloch, Paw
    Lau, Jesper
    Agersoe, Henrik
    DIABETES, 2009, 58 : A532 - A532
  • [6] Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus
    Vilsboll, Tina
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 231 - 237
  • [7] The effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutide
    Kapitza, Christoph
    Flint, Anne
    Spitzer, Heike
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A593 - A593
  • [8] Effect of Three Different Injection Sites on the Pharmacokinetics of the Once-Daily Human GLP-1 Analogue Liraglutide
    Kapitza, Christoph
    Zdravkovic, Milan
    Zijlstra, Eric
    Segel, Stine
    Heise, Tim
    Flint, Anne
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06): : 951 - 955
  • [9] Effects of the once-daily human GLP-1 analogue liraglutide on appetite and energy intake in type 2 diabetes
    Horowitz, M.
    Flint, A.
    Doran, S.
    Rasmussen, M. F.
    Kapitza, C.
    Andreasen, A. H.
    Jones, K. L.
    Zdravkovic, M.
    Chapman, I. M.
    DIABETOLOGIA, 2008, 51 : S355 - S355
  • [10] Liraglutide: A Review of the First Once-Daily GLP-1 Receptor Agonist
    Bode, Bruce
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (02): : S59 - S70
12345